Johnson & Johnson Private Limited
Clinical trials sponsored by Johnson & Johnson Private Limited, explained in plain language.
-
New hope for Tough-to-Treat blood cancer: teclistamab safety trial launches
Disease control Recruiting nowThis study is for Indian adults with multiple myeloma, a blood cancer that has returned or stopped responding to at least three prior treatments. The goal is to check the safety of a drug called teclistamab when given alone. Researchers will track side effects and see how well th…
Phase: PHASE4 • Sponsor: Johnson & Johnson Private Limited • Aim: Disease control
Last updated May 26, 2026 08:48 UTC
-
New hope for psoriatic arthritis patients: guselkumab study launches in india
Disease control Recruiting nowThis study tests the safety and effectiveness of guselkumab, a biologic drug, in 100 Indian adults with active psoriatic arthritis who did not get enough relief from standard treatments. Participants receive injections and are monitored for side effects and joint symptom improvem…
Phase: PHASE4 • Sponsor: Johnson & Johnson Private Limited • Aim: Disease control
Last updated May 18, 2026 12:07 UTC